Coffee Talk: How Later-Stage Startups can Partner with a Global Pharma Brand 461f3r

For this special Coffee Talk, I invited Sophie Park, Chief Strategist for Bayer G4A Partnerships to discuss the opportunities for later stage startups to grow and partner with a global pharma company. The Bayer G4A program has continued to grow and succeed since 2013, and it has evolved to adapt to changing market forces, new business priorities and the unprecedented acceleration of innovation that has taken place at the intersection of health and technology.  One of the challenges when an organization has a long history of success like that is that people begin to automatically associate what they knew about the program in previous years, and then overlay that to make presumptions about what the program is like this year.   For example - a lot of people think that G4A is simply an accelerator for early stage startups.  In actual fact, they also have a very powerful partnership program which is designed to attract companies that can participate in t ventures, commercial partnerships or even majority investments.   To dispel some of these myths and to give more insights on the progress and success of the G4A program and family. Links and Resources: Learn more about Bayer G4A: Web | Twitter Connect on Digital Health Today: Browse Episodes | Twitter | Linkedin | Facebook | Instagram Connect on Health Podcast Network: Browse Shows | Linkedin | Twitter | Facebook | Instagram   Digital Health Today is made possible by the of our sponsors. Thank you to University of Chicago - Master of Science in Biomedical Informatics Almirall Digital Garden Bayer G4A Cedars-Sinai Accelerator Medable Learn more about your ad choices. Visit megaphone.fm/adchoices 404x2g